TOFACITINIB
Generic: TOFACITINIB
Aurobindo Pharma LimitedManufacturer
ORALRoute
TOFACITINIB CITRATEActive Substance
2024-06-03Original Approval
TOFACITINIB is FDA application ANDA218462, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
5,295 reports
2
RHEUMATOID ARTHRITIS
4,044 reports
3
OFF LABEL USE
3,987 reports
4
PAIN
3,668 reports
5
DRUG INTOLERANCE
3,562 reports
6
FATIGUE
3,468 reports
7
RASH
3,455 reports
8
JOINT SWELLING
3,327 reports
9
SYNOVITIS
3,184 reports
10
SYSTEMIC LUPUS ERYTHEMATOSUS
3,104 reports